References
- Wallace P, Hollis D, Weaver R, Moss C. Characterization of CDC group DF-3 by cellular fatty acid analysis. J Clin Microbiol 1989; 27: 735–737
- Vandamme P, Vancanneyt M, van Belkum A, Segers P, Quint W, Kersters K, Paster B, Dewhirst F. Polyphasic analysis of strains of the genus Capnocytophaga and Centers for Disease Control group DF-3. Int J Syst Bacteriol 1996; 46: 782–791
- Wagner D, Wright J, Ansher A, Gill V. Dysgonic fermenter 3-associated gastrointestinal disease in a patient with common variable hypogammaglobulinemia. Am J Med 1988; 84: 315–318
- Aronson N, Zbick C. Dysgonic fermenter 3 bacteremia in a neutropenic patient with acute lymphocytic leukemia. J Clin Microbiol 1988; 26: 2213–2215
- Blum R, Berry C, Phillips M, Hamilos D, Koneman E. Clinical illnesses associated with isolation of dysgonic fermenter 3 from stool samples. J Clin Microbiol 1992; 30: 396–400
- Gill V, Travis L, Williams D. Clinical and microbiological observations on CDC group DF-3, a Gram-negative coccobacillus. J Clin Microbiol 1991; 29: 1589–1592
- Schønheyder H, Ejlertsen T, Frederiksen W. Isolation of a dysgonic fermenter (DF-3) from urine of a patient. Eur J Clin Microbiol Infect Dis 1991; 10: 530–531
- Bangsborg J, Frederiksen W, Bruun B. Dysgonic fermenter 3-associated abscess in a diabetic patient. J Infect 1990; 20: 237–240
- Daneshvar M, Hollis D, Moss C. Chemical characterization of clinical isolates which are similar to CDC group DF-3 bacteria. J Clin Microbiol 1991; 29: 2352–2353